<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
SCHEIN PHARMACEUTICAL, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
Delaware 001-14019 11-2726505
<S> <C> <C>
------------------------------- ------------------------ -------------------------------
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification
incorporation) Number)
</TABLE>
100 Campus Drive, Florham Park, New Jersey 07932
------------------------------------------------
(Address of principal executive offices)
(973) 593-5500
------------------------------------------------
(Registrant's telephone number, including area code)
Common Stock, par value $0.01 per share
------------------------------------------------
(Title of each class of securities covered by this form)
N/A
------------------------------------------------
(Titles of all other classes of securities for
which a duty to file reports under Section 3(a) or 15(d) remains)
Place an X in the box(es) to designate the appropriate rule provision(s) relied
upon to terminate Or suspend the duty to file reports:
[X] Rule 12g-4(a)(1)(i) [ ] Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(i)
[ ] Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(i) [ ] Rule 12h-3(b)(2)(ii)
[ ] Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(1)(ii) [ ] Rule 15d-6
Approximate number of holders of record as of the certification or notice date:
One
Pursuant to the requirements of the Securities Exchange Act of 1934, Schein
Pharmaceutical, Inc. has duly caused this Certification/Notice to be signed on
its behalf by the undersigned duly authorized person.
SCHEIN PHARMACEUTICAL, INC.
/s/ Robert C. Funsten
-----------------------------
Robert C. Funsten
August 28, 2000 Secretary
